Improving access to affordable insulin is one of the main focuses of the ACCISS Study. A key element in lowering prices is price transparency. Within this section you will find reports and other outputs relating to the price and availability of insulin and supplies in LMICs. We will continue to update this section as new imformation becomes available.
Read more about our latest price survey: Prices People Pay for Glargine: 2023 Snapshot Survey